КЛИНИЧЕСКИЕ ПЕЙЗАЖИ ПРИ COVII' 19
вого шторма, был увеличен значительно и прямо
коррелировал с кожными проявлениями.
ЛИТЕРАТУРА/REFERENCES
1.
Chen LD, Li Н, Ye YM, Wu Z, Huang YP, Zhang
WL, Lin L. A COVID-19 patient with multiple
negative results for PCR assays outside Wuhan,
China: a case report. BMC Infect Dis. 2020 Jul
16; 20(l):517.
2.
WHO:
Laboratory> diagnostics for novel
coronavirus. 2020.
emergencies/diseases/novel-
coronavirus-2019/
technical-guidance/laboratory:.
3.
Bai Y. YaoL., Wei T, Tian F, Jin D.Y, ChenL, et.
al.: Presumed asvmptomatic carrier transmission
of COVID-19. Jama 2020: 323: pp. 1406-1407.
4.
The Novel Coronavirus Pneumonia Emergency
Response Epidemiology Team: The epidemiolog
ical characteristics of an outbreak of 2019 nov
el coronavirus diseases (COVID-19) — China,
2020. China CDC Weekly 2020: 2: pp. 113-122.
5.
Nishiura H, Kobayashi T, Suzuki A., JungS.M.,
Hayashi K., Kinoshita R, et. al.: Estimation of the
asymptomatic ratio of novel coronavirus infec
tions (COVID-19). Int J Infect Dis 2020: 94: pp.
154-155.
6.
Mizumoto K., Kagaya K, Zarebski A., Chow ell
G. : Estimating the asymptomatic proportion of
coronavirus disease 2019 (COVID-19) cases on
board the Diamond Princess cruise ship, Yoko
hama, Japan, 2020. Euro Surveill 2020; 25: pp.
2000180.
7.
Ki M.: Epidemiologic characteristics of early
cases with 2019 novel coronavirus (2019-nCoV)
disease in Korea. Epidemiol Health 2020; 42:
8.
Chen J.: Pathogenicity: and transmissibility: of
2019-nCoV-A quick overview and comparison
with other emerging viruses. Microb Infect 2020;
22: pp. 69-71.
9.
Gao W.J., Li L.M.: Advances on pre symptom
atic or asymptomatic carrier transmission of
COVID-19. Chin J Epidemiol 2020: 41: pp. 485-
488.
10. Zou I... Ruan E, Huang M., Liang I... Huang H,
Hong Z., et. al.: SARS-CoV-2 viral load in upper
respiratorv specimens of infected patients. N Engl
J Med 2020: 382: pp. 1177-1179.
11.
Joob B., Wiwanitkit V: COVID-19 can present
with a rash and be mistaken for dengue. J Am
Acad Dermatol 2020: 82: pp. el77.
12.
Recalcati S.: Cutaneous manifestations in
COVID-19: a first perspective. J Eur Acad
Dermatol Venereal 2020; [e-pub ahead of print]
13. Alramthan A., Aldaraji W: A case of COVID-19
presenting in clinical picture resembling chilblains
disease. First report from the Middle East. Clin
Exp Dermatol 2020; [e-pub ahead of print]
14.
Kolivras A., Dehavay F, Delplace D., et. al.:
Coronavirus (COVID-19) infection-induced chil
blains: a case report with histopathological find
ings. JAAD Case Rep 2020; [e-pub ahead o f print]
15.
Tang N.. Bai H, Chen X., Gong J., Li 1).. Sun
Z.: Anticoagulant treatment is associated with
decreased mortality: in severe coronavirus dis
ease 2019 patients with coagulopathy. J Thromb
Haemost 2020: 18: pp. 1094-1099.
УДК: 578.834.1-07
KORONAVIRUS INFEKTSIONLI BEMORLARDA
KASALLIKNING KLINIK KO’RINISHLARI
B.K. Begmatov, B.B. Oganiezov
Ташкент давпат стоматология mcmimrymu, РУз соглиқниссацлаш вазнрлигн
XULOSA
Maqsad.Koronavirusli
infeksiya
tashxisi
tasdiq-
langan bemorda kasallanishning og 'irlik darajalarini
uchrash chastotasi va kasallik kechishining og'irlik
darajasiga ta sir qiluvchi omillar о 'rganish.
Material va metodlar.Kuzatuv
davomida Respublika
Maxsus 2-son Zangiota shifoxonasida 2020-yil avgust-
dekabr oylarida koronavirusli infeksiya tashxisi bilan
davolangan bemor orasidan 311 nafarining kasallik
tarixi hujjatlari olindi hamda retrospektiv usulda
о 'rganildi. Bemorlarda kasallik kechishining og ’irlik
darajasini baholashda klinik, laborator va instrumental
tahlil usullari qo 'llanilgan. 311 nafar bemorning 173
(55,6%) nafari ayol, 138 (44,4%) nafari erkak bo'lib
chiqdi. Bemorlarning о 'rtacha yoshi 49,5 ga teng. Be
mor laming 53 nafari yondosh kasalliklar (qon-tomir
tizimi kasalliklari, qandli diabet, о 'pkaning surunkali
kasalliklari, o'sma kasalliklari, buyrakning surunkali
kasalliklari, semirish) bilan og'riganligi aniqlandi,103
nafar bemorda zararli odat - tamaki chekishi qayd
qilindi. Bemorlarning barchasida Covid-19 tashxisipo-
limer zanjir reaksiyalari (PZR) tahlili orqali tasdiqlan-
gan. Barcha bemorlar kasallik kechishining og'irlik
darajasiga qarab 4 guruhga bo lindi.
16
MEDICINE AND INNOVATIONS |
№1, 2021
КЛИНИЧЕСКИЕ ПЕЙЗАЖИ ПРИ COVID- 19
Natija.Olib
borilgan tahlil asosida shu ma'him
bo 'ldiki, dastlabki tashxisot vaqtida kasallik I guruh -
68 nafar (21,9%) bemorda simptomsiz, II guruh - 183
nafar (58,8%) bemorda yengil, III guruh -57 nafar
(18,3%) bemorda о 'rta og 'ir hamda IVguruh - 3 nafar
(1%) bemorda og'ir shaklda kechganligi aniqlandi.
Yondosh kasalliklari bor bemorlar I guruhda 4 nafarni
(5,9%), II guruhda 21 nafarni (11,5%), III guruhda
25 nafarni (43,9%) hamda IV guruhda 3 nafarni
(100%) tashkil etdi. Zararli odatlari mavjud bemorlar
I guruhda 11 nafarni (16,2%), II guruhda 67nafarni
(36,6%), III guruhda 23 nafarni (40,4%) hamda IV
guruhda 2 nafarni (66,7%) tashkil etdi.
Xulosa.Tadqiqotlar shuni ko'rsatdiki, koronavirusli
infeksiya
bi
lan
og
'rigan
bemorlar
orasida
kasallikning yengil kechishi ко 'proq kuzatilgan.
Kasallik
kechishining
og'irlik
darajasiga
yondosh
kasalliklarning hamda zararli odatlar mavjudligi salbiy
ta sir ко 'rsatgan. Kasallikning simptomsiz kechadigan
turi bilan og'rigan bemorlar shifokorga murojaat
qilmasligi tufayli kasallikning tarqalish zanjirida faol
ishtirokchi bo 'lib hisoblanadi.
Kalit
so’zlar:koronavinisli infeksiya, og 'ir kechivchi
о 'tkir respirator sindrom
РЕЗЮМЕ
Цель:
Изучить степень тяжести заболевания у
пациента с диагностированной коронавирусной ин
фекцией, частоту возникновения и факторы, влия
ющие на тяжесть заболевания.
Материалы и методы. В
ходе наблюдения ис
пользована ретроспективная база данных паци
ентов, пролеченных с диагнозом “Коронавирусная
инфекция ” в период
август-декабрь 2020 года в Республиканской
Специализированной Больнице Зангиота №2. Для
оценки степени тяжести заболевания у пациентов
использовались клинические, лабораторные и ин
струментальные методы анализа. Из 311 пациентов
173 (55,6%) составляли женщины и 138 (44,4%)
мужчины. Средний возраст пациентов - 49,5 лет.
У 53 пациентов были диагностированы сопутству
ющие заболевания (сердечно-сосудистые заболе
вания, сахарный диабет, хронические заболевания
легких, рак, хроническое заболевание почек, ожи
рение), 103 пациента имели вредную привычку -
курение. У всех пациентов диагноз Covid-19 был
подтвержден анализом полимерных цепных ре
акций (ПЦР). Все пациенты были разделены на 4
группы по степене тяжести болезны.
Результат.На
основании анализа установлено,
что на момент постановки первичного диагноза
заболевание протекало бессимптомно в I группе
- 68 (21,9%) пациентов, легкое во II группе - у 183
(58,8%) пациентов, среднетяжелая в IIIгруппе у 57
(18,3%) пациентов и тяжелое IV группе у 3 (1%) -
пациентов. Пациенты с сопутствующими заболе
ваниями 4 (5,9%) в Iгруппе, 21 (11,5%) во II группе,
25 (43,9%) в III группе и 3 (100%) в IVгруппе. Боль
ные с вредными привычками составили 11 (16,2%)
человек в группе I, 67 (36,6%) человек во II группе,
23 (40,4%) человека в группе Ши 2 (66,7%) человека
в группе IV.
Выводы.
Клинический анализ показал, что у па
циентов с коронавируснои инфекцией чаще встре
чается легкое течения заболевания. На тяжесть
заболевания негативно повлияло наличие сопут
ствующих заболеваний и вредных привычек. Боль
ные с бессимптомными формами заболевания счи
таются активными участниками цепи передачи
заболевания, поскольку они не обращаются к врачу.
Ключевые слова:
коронавирусная инфекция, тя
желый острый респираторный синдром
ABSTRACT
The aim of the study was to study the severity of
the disease in a patient diagnosed with coronavirus
infection, the incidence and factors influencing the
severity of the disease.
Materials and methods.During
the observation,
a retrospective database of patients treated with a
diagnosis of Coronavirus infection was used in the
period August-December 2020 at the Republican
Specialized
Hospital
of
Zangiota
№2.
Clinical,
laboratory> and instrumental methods of analysis were
used to assess the severity> of the disease in patients.
Of the 311 patients, 173 (55.6%) were women and 138
(44.4%) were men. The average age of patients is
49.5 years. 53 patients were diagnosed with
concomitant diseases (cardiovascular diseases, diabetes
mellitus, chronic lung diseases, cancer, chronic kidney
disease, obesity), 103 patients had a bad habit - smoking.
In all patients, the diagnosis of Covid-19 was confirmed
by polymer chain reaction (PCR) analysis. All patients
were divided into 4 groups according to the severity of
the disease.
Results.Based
on the analysis, it was found that
at the time of the initial diagnosis, the disease was
asymptomatic in group I - 68 (21.9%) patients, lung in
group II - in 183 (58.8%) patients, moderate in group
III - in 57 (18 , 3%) patients and severe group IVin 3
(1%) - patients. Patients with concomitant diseases 4
(5.9%) in group! 21 (11.5%) in groupII, 25 (43.9%) in
group III and 3 (100%) in group IV. Patients with bad
habits were 11 (16.2%) people in group I, 67 (36.6%)
people in group II, 23 (40.4%) people in group III and
2 (66.7%) people in group group TV.
Con elusion.
Clinical analysis showed that patients
with coronavirus infection are more likely to have a
mild course of the disease. The severity> of the disease
adversely affected by the presence of concomitant
diseases and bad habits. Patients with asymptomatic
17
КЛИНИЧЕСКИЕ ПЕЙЗАЖИ ПРИ
forms of the disease are considered active participants
in the chain of transmission of the disease, since they do
not go to the doctor.
Keywords:
coronavirus
infection,
severe
acute
respiratory syndrome.
Muammoning dolzarbligi.
Koronaviras 2019-yil
oxirlarida Xitoyda epidemiya chaqirgan qo'zg'atuvchi
bo'lib, 2020-yilda boshqa davlatlarga tarqalishi tufayli
pandemiya holatini yuzaga keltirdi. 2020-yil fevral
oyidaButun Jahon Sog'liqni SaqlashTashkiloti (BJSST)
yangi kasallikkni - COVID-19, virusni "og'ir kechivchi
o'tkir respirator sindromni chaqiravchi koronavims-2"
(SARS-CoV-2 - Severe acute respiratory syndrome-
related coronavirus 2) deb nomlandi [1].
COVID-19 pandemiyasi o'tgan qisqa vaqt oralig'ida
inson
faoliyatining
barcha
jabxalarida
ijtimoiy,
iqtisodiy va siyosiy jixatdan salbiy oqibatlarga, inson
omilining maxsuldorligi kamayishiga olib keldi. Bu
holat
kasallikning og'irlik darajasigabog'liq
bo'lib,
ko'p hollarda simptomsiz, yengil yoki o'rta og'ir
shaklda
namoyon
bo'ladi.
Kasallikning
turlicha
og'irlikda kechishi qisqa davr mobaynida yaxshi
o'rganilgan
bo'lishiga
qaramasdan,
ulaming
aniq
ko'rsatkichlari haligacha noma'lum [2-10]. Ba'zi bir
manbalar kasallikning simptomsiz kechishi kogort
usulida tahlil qilganda 30-40% uchrashi aniqlangan
[10,11].
Ammo,
olibborilgan
tekshiruvlarda
bemorlami kasallik butun davomiyligi bo'ylab tahlil
qilinmaganligi, kasallik og'irlik darajasini belgilovchi
saralab olingan simptomlaming o'zaro farq qilishi
tufayli turli noaniqliklarga sabab bo'lgan. Kasallikning
simptomlarsiz kechishiga dastlabki tashxisot vaqtida
belgilaming
hali
shakllanib
ulgurmaganligi
sabab
bo'lishi, simptomlaming keyinchalik yuzaga chiqishi
mumkinligini
nazardan
chetda
qoldirmaslik
zarar.
Ayrim mualliflaming kuzatishlari natijasiga ko ra,
simptomlari
o'rtacha
kasallikning
to'rtinchi
kunda
namoyon bo'lgan [12] .Koronavirasliinfeksiyani o'rta
og'ir,
og'ir
kechishi
patogenezida
kuchli
immun
javob, endotelial disfunksiya va giperkoagulyatsion
sindrom uchligi asosiy o'rinni egallashi, natijada
gemostaz buzilishi, tromboz, nafas hamda poliorgan
yetishmovchilikka
kabi
oqibatlarga
olib
kelishi
aniqlangan.
Ko'rsatilgan
tibbiy
yordamning
keng
qamrovligi,
tezkorligiga
qaramasdan
kasallikning
bemorlarda og'ir kechishi hamda o hm holatlarining
kuzatilishi
muammo
dolzarbligini
anglatadi.
Shu
sababli, kasallikning og'irlik darajasi o'z vaqtida
to'g'ri baholanishi davo rejasining to'g'ri tanlanishiga,
davolash samaradorligini oshishiga va bemor hayot
sifatining yaxshilanishiga olib keladi.
Maqsad.Koronavirusli
infeksiya
tashxisi
tasdiqlangan
bemorlarda
kasallanishning
og'irlik
darajalarini uchrash chastotasi, ularga ta'sir qiluvchi
omillami o'rganish.
Materialvametodlar.KuzatuvdavomidaRespublika
Maxsus 2-son Zangiota shifoxonasida 2020-yil avgust-
dekabr oylarida koronavirusli infeksiya tashxisi bilan
davolangan bemor orasidan 311 nafarining kasallik
tarixi hujjatlari olindi hamda retrospektiv usulda
o'rganildi. Bemorlarda kasallik kechishining og'irlik
darajasini baholashda klinik, laborator va instrumental
tahlil usullari qo'llanilgan. 311 nafar bemoming 173
(55,6%) nafari ayol, 138 (44,4%) nafari erkak bo'lib
chiqdi. Bemorlaming o'rtacha yoshi 49,5 ga teng.
Bemorlaming 53 nafari yondosh kasalliklar (yurak-
qon tomir tizimi kasalliklari, qandli diabet, o'pkaning
surankali kasalliklari, o'sma kasalliklari, buyrakning
surankali
kasalliklari,
semirish)
bilan
og'riganligi
aniqlandi,103 nafar bemorda zararli odat - tamaki
chekishi qayd qilindi.
Bemorlaming barchasida Covid-19 tashxisi polimer
zanjir reaksiyalari (PZR) tahlili orqali tasdiqlangan.
Natijalar
va
muhokama.COVID-19
tashxisi
bilan davolangan bemorlardan 207 nafarida (67%)
isitma, 221 nafarida (71%) yo'tal, 52 nafarida (17%)
hid
va ta'm
sezgisining o'zgarishi, 19 nafarida
(6%) yutinganda og'riq, 56 nafarida (18%) terlash,
231 nafarida (74%) umumiy holsizlik, 13 nafarida
(4%) bumn bitishi, 10 nafarida (3%) qusish, 69
nafarida (22%) ich ketishi, 221 nafarida (71%)
bosh va tanadagi og'riq, 3 nafarida (1%) nafas
yetishmovchiligi aniqlangan
(diagramma 1).
Barcha
bemorlar
kasallik
kechishining
og'irlik
darajasiga qarab 4 guruhga bo'lindi.
O'rganilgan bemorlaming I gumhi - 68 nafarida
ko'rik
vaqtida
kasallik
simptomlari
aniqlanmagan
bo'lib, ulaming 41 nafarini ayollar, 27 nafarini erkaklar
tashkil qilgan.
Bemorlaming 53 nafari 50 yoshga yetmagan.
4-nafarida
yondosh
kasalliklar
nafar
bemor tamaki maxsulotlari iste'mol qilgan. Guruhdagi
barcha bemorlar davolanishning dastlabki kunlarda
ko'krak
qafasi
kompyuter
tomografiyasi
usulida
tekshirilganda ulaming 31 nafarida yallig'lanishga xos
rentgenologik belgilar aniqlangan. Davolanishning
Ichketishi, 69
Qusish, 10
Burun bitishi, 13
Terlash , 56
og
’
r
jq , o'zgarishi, 52
Nafas
Diagramma 1. Bemorlarda aniqlangan kliniksimptomlar.
Клинические симптомы, выявленные у пациентов.
Clinical symptoms identified in patients.
18
MEDICINE AND INNOVATIONS |
№1, 2021
КЛИНИЧЕСКИЕ ПЕЙЗАЖИ ПРИ COVID-19
dastlabki 10 kuni davomida ulaming 47 nafarida
kasallikka xos simptomlar yuzaga chiqqan bo’lib, 14
nafarida isitma, 28 nafarida yo’tal, 8 nafarida hid va
ta’m sezgisining o’zgarishi, 19 nafarida yutinganda
og’riq, 5 nafarida terlash kuzatilgan. 21 nafarida
kasallik klinik simptomlarsiz kechgan.Davolangan 68
nafar bemoming o’rtacha davolanish muddati 13,7±0,8
kunni tashkil qilgan.
Dastlabki tashxisga ko’ra II guruh - 183 nafar
bemorda
kasallikyengil
shaklda
kechgan
bo’lib,
ulaming 119 nafarini ayollar tashkil qilgan. 135 nafari
50 yoshga to’lmagan. 21 nafarida yondosh kasalligi
aniqlangan. 67 nafar bemor tamaki maxsulotlarini
kundalik iste’mol qilganligi qayd qilingan.II guruhdagi
bemorlamingl43
nafarida
isitma,
39
nafarida
terlash, 174 nafarida umumiy holsizlik, 135 nafarida
yo’tal, 13 nafarida burun bitishi, 8 nafarida qusish,
67 nafarida ich ketishi,161 nafarida bosh va tanadagi
og’riq, 38 nafarida ta’m va hid sezgisining buzilishi
kuzatilgan. Davolangan 183 nafar bemor ko’krak
qafasi kompyuter tomografiyasi xulosasiga ko’ra 109
nafarida zotiljamga xos belgilar - o’pka to’qimasining
5-20 % zararlanishi aniqlangan. Gipoksiya belgalari
kuzatilmagan.
Bemorlaming
o’rtacha
davolanish
muddati 21,8±1,4 kunni tashkil qilgan. Bemorlar
orasida qonning kislorodga to’yinganlik ko’rsatkichi -
saturatsiya 94,4±0,7% ga teng bo’lgan.
Bemorlaming III guruhi - 57 nafarida datlabki
tashxisga ko’ra kasallik o’rta og’ir shaklda kechgan
bo’lib, ulaming 11 nafari ayollar tashkil qilgan. 42
nafari 50 yoshdan oshgan hamda 25 nafarida yondosh
kasalliklar
aniqlangan.
23
nafar
bemor
tamaki
maxsulotlari doimiy iste’mol qilib kel gan.Gu mh a’z
ola rini ng 47 naf ari da isit ma, 9 nafarida terlash,54
nafarida umumiy holsizlik, 55 nafarida yo’tal, 1
nafarida qusish, 2 nafarida ich ketishi, barchasida bosh
va tanadagi og’riq, 5 nafarida ta’m va hid sezgisining
buzilishi davolanishning dastlabki kunlarida kuzatilgan.
Guruhdagi bemorlaming ko’krak qafasi kompyuter
tomografiyasi xulosasiga ko’ra 52 nafarida zotiljamga
xos belgilar - o’pka to’qimasining 25-45 % zararlanishi
aniqlangan. Gipoksiya belgalari 31 nafar bemorda
yuzaga kelgan, barchasi namlangan kislorod orqali
Diagramma 2. Kasallik og’irlik darajalarining uchrashi.
Частота заболеваемость! по степени тяжести.
Frequency of disease severity in patients.
nafas olgan. Davolangan bemorlarda qonning kislorod
bilan to’yinganlik ko’rsatkichi - saturatsiya o’rtacha
93±1,2% ni tashkil qilgan. Bemorlaming o’rtacha
davolanish muddati 27,3±1,7 kunni tashkil qilgan.
Davolangan bemorlaming IV guruhi - 3 nafarida
dastlabki
tashxisot
kasallikning
og’ir
kechishini
ko’rsatgan. Bemorlaming 2 nafari ayol bo’lgan.
Bemorlaming 3 lasida ham 2 dan ortiq yondosh
kasalliklar aniqlangan, у oshi 50 dan oshgan. 2 nafar
bemor tamaki maxsulotlari iste’mol qilgan. Barcha
bemorlarda
nafas
yetishmasligi,
isitma,
holsizlik,
terlash, bosh va tanadagi og’riq, yo’tal bezovta
qilgan. 1 nafar bemorda ta’m va hid sezgisining
o’zgarishi,
1
nafar
bemorda
qusish
kuzatilgan.
Kuzatuvda bo’lgan 3 nafar bemor ko’krak qafasi
kompyuter tomografiyasi xulosasiga ko’ra 2 nafarida
o’pka to’qimasining 55-65 % zararlanishi, 1 nafarida
75-80 % zararlanishi aniqlangan. Gipoksiya belgilari
3 nafar bemorda ham kuzatilgan, barchasi namlangan
kislorod orqali nafas olgan. Davolangan bemorlarda
qonning
kislorod
bilan
to’yinganlik
ko’rsatkichi
- saturatsiya o’rtacha 88±3,2% ni tashkil qilgan.
Bemorlaming o’rtacha davolanish muddati 34,5±0,7
kunni tashkil qilgan.
XULOSA
Olib borilgan tahlil asosida shu ma’lum bo’ldiki,
dastlabki tashxisot vaqtida kasallik 68 nafar (21,9%)
bemorda simptomsiz, 183 nafar (58,8%) bemorda
yengil, 57 nafar (18,3%) bemorda o’rta og’ir hamda
3 nafar (1%) bemorda og’ir shaklda kechganligi
aniqlandi
(diagramma 2).
Kasallikning simptomlarsiz
kechishi
bemoriami
shifokorga
murojaat
qilishga
undamaganligi sababli nisbatan ko’p uchrashini xulosa
qilishimiz mumkin.
Kasallikning og’ir kechishi bemorlarda oldindan
yondosh kasalliklaming mavjudligi bilan bog’liqligi
aniqlangan. Ya’ni, o’rganilgan ma’lumotlar asosida
yondosh kasalliklari bor bemorlar I guruhda 4 nafami
(5,9%), II guruhda 21 nafami (11,5%), III guruhda 25
nafami (43,9%) hamda IV guruhda 3 nafami (100%)
tashkil etdi
(diagramma 3).
Diagramma 3. Guruhlarda yondosh kasalliklari bor
bemorlaming foiz miqdori.
Процент пациентов с сопутствующими
заболеваниями в группах.
Percentage of patients with comorbidities in groups.
19
КЛИНИЧЕСКИЕ ПЕЙЗАЖИ ПРИ COVII' 19
Kasallikning kechishida zararli odatlaming mavjudligi
o'z ta'sirini ko'rsatishini ham inobatga olish lozim.
Zararli odatlari mavjud bemorlar I guruhda 11 nafami
(16,2%), II guruhda 67 nafami (36,6%), III guruhda 23
nafami (40,4%) hamda IV guruhda 2 nafami (66,7%)
tashkil etdi
(diagramma 4).
Yuqoridagi
holatlaming
mavjudligi
bemorda
kasallik kechishini og'irlashishiga, tuzalish davrining
uzayishiga
hamda
mhiy
jihatdan
tushkunlikka
tushushini sabab bo'ladi. Qolaversa, bu omillaming
inobatga
olinishi
davlat
mablag'larini
tejalishiga
va sog'liqni saqlash tizimi xodimlari zimmasidagi
yuklamani kamaytirishga yordam beradi.
0.0%
10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0%
Diagramma 4. Guruhlarda zarali odatlari bor bemorlarn-
ing miqdori. Количество пациентов с вредными
привычками в группах. The number of patients with
bad habits in groups.
ADABIYOTLAR/JIMTEPATyPA/REFERENCES
1.
World Health Organization. Director-General's
remarks at the media briefing on 2019-nCoV
on
11
February
2020.
dg/speeches/de tai l/who-di rector-genera l-s-
remarks-at-the-media-briefing-on-2019-
ncov-
on-ll-februarv-2020
(Accessed
on
February
12, 2020).
2.
Chan JF Yuan S, Kok KH. et al. A familial
cluster of pneumonia associated with the 2019
novel
coronavirus
indicating
person-to-per-
son transmission: a study of a family cluster.
Lancet
2020:
395:514.
S0140-6736(20)30154-9
3.
Liu YC, Liao CH, Chang CF, et al. A Locally
Transmitted Case of SARS-CoV-2 Infection in
Taiwan. N Engl J Med 2020: 382:1070. https://
doi. org/10.1056/nejmc2001573
4. World Health Organization. Coronavirus
disease 2019 (COVID-19) Situation Report -
28.
docs
default-source
coronavirus
e/situation-reports/20200
21
7-
sitrep-28-covid-
19 .pdf? sfvrsn=a 19cf2ad_2
(Accessed on February 18, 2020).
5.
Mizumoto K, Kagaya K, Zarebski A, Chow-
ell G. Estimating the asymptomatic propor
tion of coronavirus disease 2019 (COVID-19)
cases on board the Diamond Princess cruise
ship,
Yokohama,
Japan,
2020.
EuroSurveill
2020: 25.
7/1560-791 7.
es.2020.25.10.2000180
6.
Kimball A, Hatfield KM, Arons M, et al.
Asymptomatic
and
Presymptomatic
SARS-
CoV-2 Infections in Residents of a Long
Term Care Skilled Nursing Facility - King
County,
Washington,
March
2020.
MMWR
MorbMortalWklyRep
2020:
org/10.15585/mmwr mm6913el
7.
Wang Y, Liu Y, Liu L, et al. Clinical
Outcomes in 55 Patients With Severe Acute
Respiratory
Syndrome
Coronavirus
2
Who
Were Asymptomatic at Hospital Admission in
Shenzhen, China. J InfectDis 2020: 221:1770.
8. Sutton D, Fuchs K, D Alton M, Goffman
D.
Universal
Screening
for
SARS-CoV-2
in
Women Admitted for Delivery. N Engl J Med
2020:
382:2163.
nejmc2009316
9.
Gudbjartsson DF, Helgason A, Jonsson H,
et al. Spread of SARS-CoV-2 in the Icelandic
Population. N Engl J Med 2020: 382:2302.
10. Oran DP, Topol EJ. Prevalence of Asymptomat
ic SARS-CoV-2 Infection: A Narrative Review.
AnnlnternMed
2020.
m20-3012
11. Lavezzo E, Franchin E, Ciavarella C, et
al.
Suppression
of
a
SARS-CoV-2
outbreak
in the Italian municipality of Vo ’. Nature
2020:584:425.
. org/10.1038/
s41586-020-2488-1
12. Sakurai A, Sasaki T, Kato S, et al. Natural
History of Asymptomatic SARS-CoV-2 Infec
tion. N Engl J Med 2020:383:885.
org/10.1056/n ejmc2013020
20
MEDICINE AND INNOVATIONS |
№1, 2021